Aims: To analyze ocular fundus characteristics of patients finally diagnosed with fibrinous central serous chorioretinopathy (CSC) using multimodal imaging and compare the characteristics with images of other confusable exudative maculopathies. Methods: We retrospectively reviewed the records from 189 patients with CSC and found records on 16 patients with fibrinous CSC. Some of these 16 patients were misdiagnosed with another exudative maculopathy and were treated inappropriately. Multimodal imaging comprised fundus photography, spectral-domain optical coherence tomography (OCT), fluorescein angiography (FA), indocyanine green angiography (ICGA), and OCT angiography (OCTA), and the results were compared with those of other exudative maculopathy patients from this study. Results: Twenty-one eyes of 16 patients with a mean age of 45.44 ± 10.66 years were included in the study. The mean central choroidal thickness was 401.6 ± 47.6 μm. Eight of the 16 patients with fibrinous CSC had initially been misdiagnosed (such as with uveitis or exudative retinal detachment). On fundoscopy, a typical dark spot was seen in 19 eyes, surrounded by yellow-white exudate, corresponding to the site of leakage on FA. A hyporeflective oval-shaped vacuole-like area was observed in 14 patients. All patients showed FA signs of dye leakage and dilated choroidal vessels on ICGA. Among the patients misdiagnosed with choroidal neovascularization (CNV), OCTA showed a legible branching vessel and no signs of a blood flow signal breaking Bruch’s membrane. Conclusions: A dark spot on fundus photography images and a hyporeflective vacuole on OCT are important clinical signs that can help avoid misdiagnosing fibrinous CSC. With some small confusing lesions suspected as CNV or chronic CSC in elderly patients, OCTA may help in their identification. FA/ICGA still helps to show dye leakage sites and typical dilated choroidal vessels in fibrinous CSC, similar to other common CSCs. Multimodal imaging is mandatory in order to establish an appropriate diagnosis.

1.
Daruich
A
,
Matet
A
,
Dirani
A
,
Bousquet
E
,
Zhao
M
,
Farman
N
, et al.
Central serous chorioretinopathy: recent findings and new physiopathology hypothesis
.
Prog Retin Eye Res
.
2015
Sep
;
48
:
82
118
.
[PubMed]
1350-9462
2.
Tsai
DC
. Epidemiology of Idiopathic Central Serous Chorioretinopathy in Taiwan, 2001–2006: A Population-based Study.
2013
;8(6).
3.
Von Graefe
AK
.
Notizen und casaistische Mitheilungen vermischten Inhalts: VI. Ueber zentrale recidivirende retinitis
.
Arch Klin Exp Ophthalmol.
1866
;
12
:
211
5
.
4.
Otsuka
S
,
Ohba
N
,
Nakao
K
.
A long-term follow-up study of severe variant of central serous chorioretinopathy
.
Retina
.
2002
Feb
;
22
(
1
):
25
32
.
[PubMed]
0275-004X
5.
Bouzas
EA
,
Karadimas
P
,
Pournaras
CJ
.
Central serous chorioretinopathy and glucocorticoids
.
Surv Ophthalmol
.
2002
Sep-Oct
;
47
(
5
):
431
48
.
[PubMed]
0039-6257
6.
Gass
JD
.
Central serous chorioretinopathy and white subretinal exudation during pregnancy.
Archives of ophthalmology (Chicago, Ill : 1960).
1991
;109(5):677-81.
7.
Gass
JD
.
Bullous retinal detachment. An unusual manifestation of idiopathic central serous choroidopathy
.
Am J Ophthalmol
.
1973
May
;
75
(
5
):
810
21
.
[PubMed]
0002-9394
8.
Singh
SR
,
Dogra
M
,
Dogra
MR
.
Dark Spot in Fibrinous Central Serous Chorioretinopathy
.
JAMA Ophthalmol
.
2018
Oct
;
136
(
10
):
e182924
.
[PubMed]
2168-6165
9.
Fujimoto
H
,
Gomi
F
,
Wakabayashi
T
,
Sawa
M
,
Tsujikawa
M
,
Tano
Y
.
Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
Ophthalmology.
2008
;115(9):1494-500, 500.e1-2.
10.
Ricketti
PA
,
Unkle
DW
,
Cleri
DJ
,
Prenner
JL
,
Coluccielo
M
,
Ricketti
AJ
.
Central serous chorioretinopathy secondary to corticosteroids in patients with atopic disease
.
Allergy Asthma Proc
.
2015
Mar-Apr
;
36
(
2
):
123
9
.
[PubMed]
1088-5412
11.
Balaratnasingam
C
,
Freund
KB
,
Tan
AM
,
Mrejen
S
,
Hunyor
AP
,
Keegan
DJ
, et al.
Bullous Variant of Central Serous Chorioretinopathy: Expansion of Phenotypic Features Using Multimethod Imaging
.
Ophthalmology
.
2016
Jul
;
123
(
7
):
1541
52
.
[PubMed]
0161-6420
12.
Parchand
S
,
Gupta
V
,
Gupta
A
,
Dogra
MR
,
Singh
R
,
Sharma
A
.
Dark spot in fibrinous central serous chorioretinopathy masquerading choroiditis
.
Ocul Immunol Inflamm
.
2013
Jun
;
21
(
3
):
201
6
.
[PubMed]
0927-3948
13.
Kim
HC
,
Cho
WB
,
Chung
H
.
Morphologic changes in acute central serous chorioretinopathy using spectral domain optical coherence tomography
.
Korean J Ophthalmol
.
2012
Oct
;
26
(
5
):
347
54
.
[PubMed]
1011-8942
14.
Eandi
CM
,
Ober
M
,
Iranmanesh
R
,
Peiretti
E
,
Yannuzzi
LA
.
Acute central serous chorioretinopathy and fundus autofluorescence
.
Retina
.
2005
Dec
;
25
(
8
):
989
93
.
[PubMed]
0275-004X
15.
Kahloun
R
,
Chebbi
A
,
Amor
SB
,
Ksiaa
I
,
Nacef
L
,
Khairallah
M
.
Multimodal imaging for the diagnosis of an atypical case of central serous chorioretinopathy
.
Middle East Afr J Ophthalmol
.
2014
Oct-Dec
;
21
(
4
):
354
7
.
[PubMed]
0974-9233
16.
Papadia
M
,
Jeannin
B
,
Herbort
CP
.
Central Serous Chorioretinopathy Misdiagnosed as Posterior Uveitis and the Vicious Circle of Corticosteroid Therapy
.
J Ophthalmic Vis Res
.
2015
Jul-Sep
;
10
(
3
):
303
8
.
[PubMed]
2008-2010
17.
Khairallah
M
,
Kahloun
R
,
Tugal-Tutkun
I
.
Central serous chorioretinopathy, corticosteroids, and uveitis
.
Ocul Immunol Inflamm
.
2012
Apr
;
20
(
2
):
76
85
.
[PubMed]
0927-3948
18.
Matsumoto
H
,
Kishi
S
,
Sato
T
,
Mukai
R
.
Fundus autofluorescence of elongated photoreceptor outer segments in central serous chorioretinopathy
.
Am J Ophthalmol
.
2011
Apr
;
151
(
4
):
617
623.e1
.
[PubMed]
0002-9394
19.
Spaide
RF
,
Klancnik
JM
 Jr
.
Fundus autofluorescence and central serous chorioretinopathy
.
Ophthalmology
.
2005
May
;
112
(
5
):
825
33
.
[PubMed]
0161-6420
20.
Imamura
Y
,
Fujiwara
T
,
Spaide
RF
.
Fundus autofluorescence and visual acuity in central serous chorioretinopathy
.
Ophthalmology
.
2011
Apr
;
118
(
4
):
700
5
.
[PubMed]
0161-6420
21.
Rajesh
B
,
Kaur
A
,
Giridhar
A
,
Gopalakrishnan
M
.
“VACUOLE” SIGN ADJACENT TO RETINAL PIGMENT EPITHELIAL DEFECTS ON SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY IN CENTRAL SEROUS CHORIORETINOPATHY ASSOCIATED WITH SUBRETINAL FIBRIN
.
Retina
.
2017
Feb
;
37
(
2
):
316
24
.
[PubMed]
0275-004X
22.
Min
JY
,
Lv
Y
,
Yu
S
,
Gong
YY
.
Findings of OCT-angiography compared to fluorescein and indocyanine green angiography in central serous chorioretinopathy
.
Lasers Surg Med
.
2018
Dec
;
50
(
10
):
987
93
.
[PubMed]
0196-8092
23.
Bhende
M
,
Shetty
S
,
Parthasarathy
MK
,
Ramya
S
.
Optical coherence tomography: A guide to interpretation of common macular diseases
.
Indian J Ophthalmol
.
2018
Jan
;
66
(
1
):
20
35
.
[PubMed]
0301-4738
24.
Pichi
F
,
Ciardella
AP
,
Cunningham
ET
 Jr
,
Morara
M
,
Veronese
C
,
Jumper
JM
, et al.
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy
.
Retina
.
2014
Feb
;
34
(
2
):
373
84
.
[PubMed]
0275-004X
25.
Woolston
SL
,
Dhanireddy
S
,
Marrazzo
J
.
Ocular Syphilis: a Clinical Review
.
Curr Infect Dis Rep
.
2016
Nov
;
18
(
11
):
36
.
[PubMed]
1523-3847
26.
Salman
A
,
Parmar
P
,
Rajamohan
M
,
Vanila
CG
,
Thomas
PA
,
Jesudasan
CA
.
Optical coherence tomography in choroidal tuberculosis
.
Am J Ophthalmol
.
2006
Jul
;
142
(
1
):
170
2
.
[PubMed]
0002-9394
27.
Srour
M
,
Querques
G
,
Rostaqui
O
,
Souied
EH
.
Early spectral-domain optical coherence tomography findings in unilateral acute idiopathic maculopathy
.
Retina
.
2013
Nov-Dec
;
33
(
10
):
2182
4
.
[PubMed]
0275-004X
28.
Haruta
H
,
Sawa
M
,
Saishin
Y
,
Ohguro
N
,
Tano
Y
.
Clinical findings in unilateral acute idiopathic maculopathy: new findings in acute idiopathic maculopathy
.
Int Ophthalmol
.
2010
Apr
;
30
(
2
):
199
202
.
[PubMed]
0165-5701
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.